AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
-12.39%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$945M
AUM Growth
–
Cap. Flow
+$945M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
9
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$382M |
| 2 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$248M |
| 3 |
Erasca
ERAS
|
$172M |
| 4 |
VERV
Verve Therapeutics
VERV
|
$92.5M |
| 5 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$43.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $382M | 40.37% |
+2,912,872
| New | +$382M |
|
|
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
| $248M | 26.22% |
+36,335,375
| New | +$248M |
|
|
3
Erasca
ERAS
$445M
| $172M | 18.22% |
+11,055,554
| New | +$172M |
|
|
VERV
4
DELISTED
Verve Therapeutics
VERV
| $92.5M | 9.79% |
+2,508,809
| New | +$92.5M |
|
|
OMIC
5
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $43.9M | 4.65% |
+3,798,926
| New | +$43.9M |
|
|
RUBY
6
DELISTED
Rubius Therapeutics, Inc
RUBY
| $3.39M | 0.36% |
+349,908
| New | +$3.39M |
|
7
Natera
NTRA
$23.1B
| $3M | 0.32% |
+32,098
| New | +$3M |
|
|
ZY
8
DELISTED
Zymergen Inc. Common Stock
ZY
| $797K | 0.08% |
+119,205
| New | +$797K |
|
9
Pulmatrix
PULM
$18M
| $19K | ﹤0.01% |
+43,639
| New | +$19K |
|